Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Business
Karl Matchett

Fears over £160bn blow to London’s stock market as AstraZeneca considers listing move to US

The boss of AstraZeneca, the biggest company on the London Stock Exchange, has discussed shifting the pharmaceutical firm’s stock market listing to the US.

Such a move would be the biggest hit to the stock market yet, following some huge departures such as £10bn financials firm Wise and £40bn mining business Glencore, among others.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.